|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 10/30/19 Petmed Express Inc 10-Q 9/30/19 43:2.6M RDG Filings/FA |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 367K
2: EX-31.1 Certification -- §302 - SOA'02 HTML 22K
3: EX-31.2 Certification -- §302 - SOA'02 HTML 22K
4: EX-32.1 Certification -- §906 - SOA'02 HTML 18K
21: R1 Document And Entity Information HTML 45K
40: R2 Condensed Consolidated Balance Sheets (Current HTML 94K
Period Unaudited)
28: R3 Condensed Consolidated Balance Sheets (Current HTML 40K
Period Unaudited) (Parentheticals)
15: R4 Condensed Consolidated Statements of Comprehensive HTML 82K
Income (Unaudited)
22: R5 Condensed Consolidated Statements of Cash Flows HTML 83K
(Unaudited)
41: R6 Note 1 - Summary of Significant Accounting HTML 34K
Policies
29: R7 Note 2 - Revenue Recognition HTML 81K
16: R8 Note 3 - Net Income Per Share HTML 48K
20: R9 Note 4 - Stock-based Compensation HTML 26K
35: R10 Note 5 - Fair Value HTML 22K
38: R11 Note 6 - Changes in Shareholders' Equity and HTML 58K
Comprehensive Income
27: R12 Note 7 - Commitments and Contingencies HTML 25K
14: R13 Note 8 - Income Taxes HTML 22K
34: R14 Note 9 - Subsequent Events HTML 19K
37: R15 Significant Accounting Policies (Policies) HTML 38K
26: R16 Note 2 - Revenue Recognition (Tables) HTML 74K
13: R17 Note 3 - Net Income Per Share (Tables) HTML 45K
33: R18 Note 6 - Changes in Shareholders' Equity and HTML 55K
Comprehensive Income (Tables)
39: R19 Note 1 - Summary of Significant Accounting HTML 21K
Policies (Details Textual)
24: R20 Note 2 - Revenue Recognition (Details Textual) HTML 17K
19: R21 Note 2 - Revenue Recognition - Disaggregation of HTML 35K
Revenue by Type (Details)
32: R22 Note 3 - Net Income Per Share (Details Textual) HTML 16K
43: R23 Note 3 - Net Income Per Share - Basic and Diluted HTML 46K
Net Income Per Share (Details)
23: R24 Note 4 - Stock-based Compensation (Details HTML 45K
Textual)
18: R25 Note 5 - Fair Value (Details Textual) HTML 17K
31: R26 Note 6 - Changes in Shareholders' Equity and HTML 23K
Comprehensive Income (Details Textual)
42: R27 Note 6 - Changes in Shareholders' Equity and HTML 43K
Comprehensive Income: - Schedule of Changes in
Shareholders' Equity (Details)
25: R28 Note 7 - Commitments and Contingencies (Details HTML 18K
Textual)
17: R29 Note 8 - Income Taxes (Details Textual) HTML 23K
11: R30 Note 9 - Subsequent Events (Details Textual) HTML 27K
36: XML IDEA XML File -- Filing Summary XML 73K
30: EXCEL IDEA Workbook of Financial Reports XLSX 32K
5: EX-101.INS XBRL Instance -- pets-20190930 XML 660K
7: EX-101.CAL XBRL Calculations -- pets-20190930_cal XML 80K
8: EX-101.DEF XBRL Definitions -- pets-20190930_def XML 480K
9: EX-101.LAB XBRL Labels -- pets-20190930_lab XML 409K
10: EX-101.PRE XBRL Presentations -- pets-20190930_pre XML 500K
6: EX-101.SCH XBRL Schema -- pets-20190930 XSD 77K
12: ZIP XBRL Zipped Folder -- 0001437749-19-020948-xbrl Zip 62K
Exhibit 31.2
CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER
PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Bruce S. Rosenbloom, certify that:
|
1. |
I have reviewed this report on Form 10-Q for the quarter ended September 30, 2019 of PetMed Express, Inc.; |
|
2. |
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
|
3. |
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
|
4. |
The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5. |
The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of the internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s Board of Directors (or persons performing the equivalent functions): |
a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
|
|
||
|
|
|
|
|
|
|
By: |
/s/ Bruce S. Rosenbloom |
|
|
|
|
||
|
|
Chief Financial Officer |
|
|
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 10/30/19 | None on these Dates | ||
| For Period end: | 9/30/19 | |||
| List all Filings | ||||